{"id":"NCT00344968","sponsor":"Alimera Sciences","briefTitle":"Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema","officialTitle":"A Randomized, Double-Masked, Parallel Group, Multi-center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 μg/Day and ASI-001B 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects With Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2009-12","completion":"2010-12","firstPosted":"2006-06-27","resultsPosted":"2014-05-07","lastUpdate":"2014-05-07"},"enrollment":956,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"fluocinolone acetonide","otherNames":[]},{"type":"DRUG","name":"Fluocinolone Acetonide","otherNames":[]},{"type":"PROCEDURE","name":"Standard of care laser photocoagulation","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"SHAM_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema.","primaryOutcome":{"measure":"Visual Acuity","timeFrame":"36 months","effectByArm":[{"arm":"Sham Comparator","deltaMin":18.9,"sd":18.01},{"arm":"Fluocinolone Acetonide: 0.2 ug/Day Implant","deltaMin":28.7,"sd":19.04},{"arm":"Fluocinolone Acetonide: 0.5 ug/Day Implant","deltaMin":27.8,"sd":18.96}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33206392","30569759"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":112,"n":185},"commonTop":["Cataract","Intraocular pressure increased","Cataract","Myodesopsia","Eye pain"]}}